000139444 001__ 139444
000139444 005__ 20210129212606.0
000139444 0247_ $$2doi$$a10.2967/jnumed.113.129007
000139444 0247_ $$2wos$$aWOS:000333910600011
000139444 0247_ $$2altmetric$$aaltmetric:2241041
000139444 0247_ $$2pmid$$apmid:24578243
000139444 037__ $$aFZJ-2013-05433
000139444 082__ $$a610
000139444 1001_ $$0P:(DE-Juel1)141877$$aFilss, Christian$$b0$$eCorresponding author$$ufzj
000139444 245__ $$aComparison of $^{18}$F-FET PET and perfusion weighted MR imaging: a PET-MR imaging hybrid study in patients with brain tumors.
000139444 260__ $$aReston, Va.$$bSNM$$c2014
000139444 264_1 $$2Crossref$$3online$$bSociety of Nuclear Medicine$$c2014-02-27
000139444 264_1 $$2Crossref$$3print$$bSociety of Nuclear Medicine$$c2014-04-01
000139444 264_1 $$2Crossref$$3print$$bSociety of Nuclear Medicine$$c2014-04-01
000139444 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1416990380_32692
000139444 3367_ $$2DataCite$$aOutput Types/Journal article
000139444 3367_ $$00$$2EndNote$$aJournal Article
000139444 3367_ $$2BibTeX$$aARTICLE
000139444 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000139444 3367_ $$2DRIVER$$aarticle
000139444 520__ $$aPET using O-(2-$^{18}$F-fluoroethyl)-L-tyrosine ($^{18}$F-FET) provides important diagnostic information in addition to that from conventional MR imaging on tumor extent and activity of cerebral gliomas. Recent studies suggest that perfusion-weighted MR imaging (PWI), especially maps of regional cerebral blood volume (rCBV), may provide similar diagnostic information. In this study, we directly compared $^{18}$F-FET PET and PWI in patients with brain tumors. Methods: Fifty-six patients with gliomas were investigated using static $^{18}$F-FET PET and PWI. For comparison, 8 patients with meningiomas were included.We generated a set of tumor and reference volumes of interest (VOIs) based on morphologic MR imaging and transferred these VOIs to the corresponding $^{18}$F-FET PET scans and PWI maps.  From these VOIs, tumor-to-brain ratios (TBR) were calculated, and normalized histograms were generated for $^{18}$F-FET PET and rCBV maps. Furthermore, in rCBV maps and in $^{18}$F-FET PET scans, tumor volumes, their spatial congruence, and the distance between the local hot spots were assessed. Results: For patients with glioma, TBR was significantly higher in $^{18}$F-FET PET than in rCBV maps (TBR, 2.28 ± 0.99 vs. 1.62 ± 1.13; P < 0.001). Histogram analysis of the VOIs revealed that $^{18}$F-FET scans could clearly separate tumor from background.  In contrast, deriving this information from rCBV maps was difficult. Tumor volumes were significantly larger in $^{18}$F-FET PET than in rCBV maps (tumor volume, 24.3 ± 26.5 mL vs. 8.9 ± 13.9 mL; P < 0.001). Accordingly, spatial overlap of both imaging parameters was poor (congruence, 11.0%), and mean distance between the local hot spots was 25.4 ± 16.1 mm. In meningioma patients, TBR was higher in rCBV maps than in $^{18}$F-FET PET (TBR, 5.33 ± 2.63 vs. 2.37 ± 0.32; P < 0.001) whereas tumor volumes were comparable. Conclusion: In patients with cerebral glioma, tumor imaging with $^{18}$F-FET PET and rCBV yields different information. $^{18}$F-FET PET shows considerably higher TBRs and larger tumor volumes than rCBV maps. The spatial congruence of both parameters is poor. The locations of the local hot spots differ considerably. Taken together, our data show that metabolically active tumor tissue of gliomas as depicted by amino acid PET is not reflected by rCBV as measured with PWI.
000139444 536__ $$0G:(DE-HGF)POF2-333$$a333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)$$cPOF2-333$$fPOF II$$x0
000139444 536__ $$0G:(DE-HGF)POF2-332$$a332 - Imaging the Living Brain (POF2-332)$$cPOF2-332$$fPOF II$$x1
000139444 536__ $$0G:(DE-HGF)POF2-89573$$a89573 - Neuroimaging (POF2-89573)$$cPOF2-89573$$fPOF II T$$x2
000139444 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b1$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131627$$aStoffels, Gabriele$$b2$$ufzj
000139444 7001_ $$0P:(DE-HGF)0$$aSabel, M.$$b3
000139444 7001_ $$0P:(DE-HGF)0$$aWittsack, H. J.$$b4
000139444 7001_ $$0P:(DE-HGF)0$$aTurowski, B.$$b5
000139444 7001_ $$0P:(DE-HGF)0$$aAntoch, G.$$b6
000139444 7001_ $$0P:(DE-Juel1)142359$$aZhang, Ke$$b7$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b8$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b9$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131794$$aShah, N. J.$$b10$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131768$$aHerzog, Hans$$b11$$ufzj
000139444 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b12$$ufzj
000139444 77318 $$2Crossref$$3journal-article$$a10.2967/jnumed.113.129007$$b : Society of Nuclear Medicine, 2014-02-27$$n4$$p540-545$$tJournal of Nuclear Medicine$$v55$$x0161-5505$$y2014
000139444 773__ $$0PERI:(DE-600)2040222-3$$a10.2967/jnumed.113.129007$$n4$$p540-545$$tJournal of nuclear medicine$$v55$$x0161-5505$$y2014
000139444 8564_ $$uhttps://juser.fz-juelich.de/record/139444/files/FZJ-2013-05433.pdf$$yRestricted
000139444 909CO $$ooai:juser.fz-juelich.de:139444$$pVDB
000139444 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000139444 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000139444 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000139444 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000139444 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000139444 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000139444 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000139444 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000139444 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000139444 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000139444 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000139444 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000139444 9141_ $$y2014
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)141877$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)142359$$aForschungszentrum Jülich GmbH$$b7$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich GmbH$$b8$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich GmbH$$b9$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich GmbH$$b10$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131768$$aForschungszentrum Jülich GmbH$$b11$$kFZJ
000139444 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich GmbH$$b12$$kFZJ
000139444 9132_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bPOF III$$lKey Technologies$$vDecoding the Human Brain$$x0
000139444 9131_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000139444 9131_ $$0G:(DE-HGF)POF2-332$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vImaging the Living Brain$$x1
000139444 9131_ $$0G:(DE-HGF)POF2-89573$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vNeuroimaging$$x2
000139444 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000139444 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000139444 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x2
000139444 9201_ $$0I:(DE-82)080010_20140620$$kJARA-BRAIN$$lJARA-BRAIN$$x3
000139444 980__ $$ajournal
000139444 980__ $$aVDB
000139444 980__ $$aI:(DE-Juel1)INM-3-20090406
000139444 980__ $$aI:(DE-Juel1)INM-4-20090406
000139444 980__ $$aI:(DE-Juel1)INM-5-20090406
000139444 980__ $$aI:(DE-82)080010_20140620
000139444 980__ $$aUNRESTRICTED
000139444 981__ $$aI:(DE-Juel1)INM-4-20090406
000139444 981__ $$aI:(DE-Juel1)INM-5-20090406